Patents by Inventor Daryl David Rees

Daryl David Rees has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical compounds
    Patent number: 7589123
    Abstract: Compounds of general formula I: wherein: R1 and R2 are, independently of each other, selected from hydrogen, optionally substituted C1-10alkyl, optionally substituted —CO—(C1-10alkyl), optionally substituted C3-10cycloalkyl, optionally substituted —CO—(C3-10cycloalkyl), optionally substituted C2-10alkenyl, optionally substituted —CO—(C2-10alkenyl), optionally substituted aryl, and optionally substituted —CO-aryl, or R1 and R2 together represent an optionally substituted saturated or unsaturated C1-10alkylidene group, or an optionally substituted saturated or unsaturated C3-10cycloalkylidene group, or R1 and R2 together with the carbon atom to which they are attached represent an optionally substituted saturated or unsaturated organic ring containing 3, 4, 5, 6, 7 or 8 ring carbon atoms and optionally 1, 2 or 3 ring heteroatoms selected from O, N and S; R3, which may be the same as, or different from, either of R1 and R2, is selected from optionally substituted C1-10alkyl, optionally substituted C3-10cycl
    Type: Grant
    Filed: July 5, 2007
    Date of Patent: September 15, 2009
    Assignee: Phytopharm PLC
    Inventors: Daryl David Rees, Phillip James Gunning, Antonia Orsi, Patrick A. Howson, Paul Barraclough, Noelle Callizot
  • APPETITE SUPPRESSANT COMPOSITIONS
    Publication number: 20070207227
    Abstract: An inherently nourishing edible appetite suppressant product comprising a steroidal glycoside, preferably obtainable from plants of the Asclepiadaceae family, the product being in the unit serving, having a weight of from 20 to 600 grams, and having the energy density of from 1.6 to 23 kilojoules per gram of product. A dietary regimen is also disclosed.
    Type: Application
    Filed: September 12, 2006
    Publication date: September 6, 2007
    Applicant: CONOPCO, INC., D/B/A UNILEVER, A CORPORATION OF NEW YORK
    Inventors: Salomon Leendert ABRAHAMSE, Kevin John POVEY, Daryl David REES
  • Nitric oxide synthase inhibitors
    Patent number: 6620848
    Abstract: The present invention relates to novel amidino compound of formula (I): to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use as selective inhibitors of inducible nitric oxide synthase.
    Type: Grant
    Filed: August 15, 2001
    Date of Patent: September 16, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Richard Mansfield Beams, Martin James Drysdale, Karl Witold Franzmann, Anthony Joseph Frend, Harold Francis Hodson, Richard Graham Knowles, Daryl David Rees, David Alan Sawyer
  • Nitric oxide synthase inhibitors
    Patent number: 6369272
    Abstract: The present invention relates to novel amidino compound of formula (I). to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use as selective inhibitors of inducible nitric oxide synthase.
    Type: Grant
    Filed: August 24, 1999
    Date of Patent: April 9, 2002
    Assignee: GlaxoSmithKline
    Inventors: Richard Mansfield Beams, Martin James Drysdale, Karl Witold Franzmann, Anthony Joseph Frend, Harold Francis Hodson, Richard Graham Knowles, Daryl David Rees, David Alan Sawyer
  • Nitric oxide synthase inhibitors
    Publication number: 20020010366
    Abstract: The present invention relates to novel amidino compound of formula (I).
    Type: Application
    Filed: August 15, 2001
    Publication date: January 24, 2002
    Inventors: Richard Mansfield Beams, Martin James Drysdale, Karl Witold Franzmann, Anthony Joseph Frend, Harold Francis Hodson, Richard Graham Knowles, Daryl David Rees, David Alan Sawyer